Vesey Street Capital Partners

Description

Private Equity Partner of Choice for Lower Middle-Market Healthcare Services Companies Vesey Street Capital Partners (VSCP) is a New York City-based private equity firm specializing in buyouts of lower middle-market healthcare services businesses. Established in 2014, VSCP targets founder-led businesses and corporate carve-outs with a track record of robust cash flow and minimal reimbursement risk. These companies typically have EBITDA in the range of $10-20 million and the firm utilizes conservative balance sheet leverage. VSCP seeks to create value by growing revenue and EBITDA both organically and via M&A. With a collective experience of more than 100 years in analyzing and investing in healthcare services companies, VSCP's team holds profound industry expertise and strong connections with industry leaders, enabling them to concentrate on identifying opportunities from a proprietary deal flow with focus on founder-led businesses and corporate carve-outs. VSCP invests on behalf of a wide array of Limited Partners, including asset management firms, family offices, pension funds, and other institutional investors. The firm prides itself on having great alignment with all its key stakeholders.

Vesey Street Capital Partners is a New York-based PE firm executing control buyouts and corporate carve-outs of lower-middle-market healthcare services businesses (target EBITDA $10–20M, equity cheque $75–120M), growing platforms organically and via add-on M&A. No current dental holdings are confirmed, but their multi-site healthcare services buyout mandate makes them a plausible dental or oral-health platform acquirer.

VSCP is a dedicated lower-middle-market healthcare services PE firm with $1B+ capital deployed, active platform buyouts (e.g. ComplexCare Solutions carve-out in Jan 2025, Orthopaedic Solutions Management, Gastro MD), and an explicit mandate to grow platforms via M&A — making them a credible acquirer of dental or multi-site healthcare services platforms.

enriched 2026-05-05

Financials